ASMANEX HFA
ICS MDI
Mometasone furoate · Organon
Active Medication & Mechanism
- Mometasone furoate ICS50 mcg, 100 mcg, or 200 mcg per actuation
Synthetic corticosteroid with potent anti-inflammatory properties. Reduces airway inflammation through suppression of inflammatory cell recruitment and cytokine production.
FDA-Approved Dosing — Strength × Indication
Strength Regimen Asthma
100 mcg
2 inhalations twice daily → 400 mcg
FDA Approved
Adults (previously on bronchodilators alone or ICS) Recommended starting dose for patients previously on bronchodilators alone or ICS therapy.
200 mcg
2 inhalations twice daily → 800 mcg
FDA Approved
Adults (previously on oral corticosteroids) Maximum recommended dose. For patients previously on oral corticosteroids.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
100 mcg 2 inhalations twice daily → 400 mcg
Asthma FDA Approved
Adults (previously on bronchodilators alone or ICS) Recommended starting dose for patients previously on bronchodilators alone or ICS therapy.
200 mcg 2 inhalations twice daily → 800 mcg
Asthma FDA Approved
Adults (previously on oral corticosteroids) Maximum recommended dose. For patients previously on oral corticosteroids.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Not a rescue inhaler. Not for acute relief. Use a SABA.